Another light pollution/health study using the massive UK #BioBank dataset. “Our findings provide evidence that a higher #ALAN exposure is associated with an increased risk of incident [ulcerative colitis], with a significant dose-response relationship, but not with [Crohn’s disease]. Further studies are needed to elucidate the impact of outdoor ALAN on disease pathogenesis and outcomes.”
https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1704450/abstract

1.1 Background Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, and environmental factors are believed to ...
Civilisation is often defined by what it chooses not to let disappear. At #Uzhhorod National #University, scientists have built a #biobank that advances #genomics and type 1 #diabetes #research, even as #war continues. It already supports #international research and teaching, and aims to represent the #genetic #diversity of #Ukraine where there was once a blank space on the map. But biology is unforgiving. Without reliable #electricity, years of work and thousands of samples simply thaw into loss. A large backup battery can keep this knowledge alive.
So here is the plain question: would you like to support both Science AND Ukraine?
If yes, please chip in to my friends’ fundraiser. Some things are worth keeping powered on. https://gofund.me/92339d478
⚠️ This implies that in survivors of mild COVID-19, which is most people, over 1 in 3 cases of new-onset dementia is due to COVID-19 ⚠️
adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection
compared with those in propensity-score-matched controls without COVID-19 and in individuals with non-COVID respiratory illnesses
COVID-19 survivors had a higher likelihood of developing new-onset dementia compared to uninfected controls
association between COVID-19 and all-cause dementia (adjusted Hazard Ratio: 1.58)
The underlying pathophysiology likely involves prothrombotic, inflammatory, and microvascular dysfunction mechanisms, contributing to cerebral small vessel disease, blood-brain barrier disruption, and chronic cerebral hypoperfusion, ultimately leading to cognitive impairments and dementia
https://www.nature.com/articles/s44400-025-00034-y
#SARSCoV2 #COVID #COVID19 #CovidIsNotOver #SARS2 #MaskUp #dementia #biobank #LongCOVID

COVID-19 is associated with long-term neurological complications, but its impact on new-onset dementia (NOD), particularly vascular dementia (VaD) and Alzheimer’s disease (AD), remains unclear. We observed adults aged 50 years and older from the UK Biobank over a median observational period exceeding two years following COVID-19 infection. Incidences of various types of dementia (including all-cause dementia, AD, and VaD) in these individuals were compared with those in propensity-score-matched controls without COVID-19 and in individuals with non-COVID respiratory illnesses (including both non-communicable respiratory conditions and non-COVID respiratory tract infections). We found that COVID-19 survivors had a higher likelihood of developing NOD compared to uninfected controls. This increased risk was primarily driven by VaD rather than AD; however, the risk did not surpass that observed among individuals with non-COVID respiratory illnesses. Notably, individuals with pre-existing mental health conditions were particularly vulnerable, exhibiting significantly higher risks of VaD following COVID-19 infection.
[5/5] Im Fokus des Beitrags des Instituts für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie (ILP) der #CharitéBerlin steht die technische Umsetzung der Befüllung der Probenröhrchen und die Aufbereitung der Blutbestandteile. Ziel des Projekts Multipen ist es, die Probenqualität zu verbessern.
👉 https://ilp.charite.de/metas/meldung/artikel/detail/ein_neuartiges_blutentnahme_und_lagerungssystem